Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$23.14 - $34.72 $56,808 - $85,237
-2,455 Reduced 24.55%
7,547 $219,000
Q1 2024

May 03, 2024

BUY
$33.4 - $45.2 $1,837 - $2,486
55 Added 0.55%
10,002 $354,000
Q4 2023

Feb 09, 2024

SELL
$34.21 - $44.59 $7,320 - $9,542
-214 Reduced 2.11%
9,947 $433,000
Q3 2023

Nov 13, 2023

SELL
$37.8 - $45.97 $4,573 - $5,562
-121 Reduced 1.18%
10,161 $388,000
Q2 2023

Aug 08, 2023

SELL
$37.95 - $58.98 $4,743 - $7,372
-125 Reduced 1.2%
10,282 $422,000
Q1 2023

May 04, 2023

SELL
$52.61 - $60.49 $5,261 - $6,049
-100 Reduced 0.95%
10,407 $597,000
Q4 2022

Feb 10, 2023

SELL
$42.17 - $58.6 $19,566 - $27,190
-464 Reduced 4.23%
10,507 $589,000
Q3 2022

Nov 04, 2022

BUY
$42.28 - $57.17 $10,104 - $13,663
239 Added 2.23%
10,971 $465,000
Q2 2022

Aug 12, 2022

SELL
$53.86 - $66.52 $17,773 - $21,951
-330 Reduced 2.98%
10,732 $580,000
Q1 2022

May 09, 2022

SELL
$62.86 - $69.24 $28,727 - $31,642
-457 Reduced 3.97%
11,062 $711,000
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $7,933 - $9,302
-127 Reduced 1.09%
11,519 $771,000
Q3 2021

Nov 09, 2021

BUY
$64.97 - $76.19 $129,160 - $151,465
1,988 Added 20.58%
11,646 $797,000
Q2 2021

Aug 09, 2021

SELL
$66.79 - $76.63 $1,870 - $2,145
-28 Reduced 0.29%
9,658 $659,000
Q1 2021

May 05, 2021

SELL
$62.63 - $71.15 $44,905 - $51,014
-717 Reduced 6.89%
9,686 $669,000
Q4 2020

Feb 09, 2021

SELL
$43.31 - $66.55 $16,501 - $25,355
-381 Reduced 3.53%
10,403 $676,000
Q3 2020

Nov 06, 2020

BUY
$43.33 - $51.72 $64,518 - $77,011
1,489 Added 16.02%
10,784 $509,000
Q2 2020

Aug 07, 2020

SELL
$41.42 - $55.57 $167,212 - $224,336
-4,037 Reduced 30.28%
9,295 $437,000
Q1 2020

May 08, 2020

BUY
$36.67 - $61.04 $488,884 - $813,785
13,332 New
13,332 $595,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.91B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.